Jose Zea

Jose Zea has a diverse work experience in the field of entrepreneurship and AI. Jose is currently the CEO and Co-founder of Arkangel AI, a healthcare organization that utilizes artificial intelligence technology. The company has achieved notable recognition such as winning the Everis Awards 2020 and being selected by Novartis as key partners in the fight against Malaria.

Jose was also a CDL Alumni in the AI sector as part of the CDL-Montreal program. Jose has been involved in various ventures and accelerator programs, including being a part of MaRS Discovery District's healthcare portfolio and the Google for Startups Accelerator Canada.

Furthermore, Jose has been an entrepreneur in the health portfolio at Next Canada and District 3 Innovation. Jose also co-founded a startup incubator called LAB1 in Colombia.

In summary, Jose Zea has a strong background in entrepreneurship and AI, with experience in various organizations and programs focused on utilizing technology to address healthcare challenges.

Jose Zea's education history is as follows:

From 2018 to 2019, Jose attended the MIT Sloan School of Management where they pursued Executive Education in Strategy & Innovation.

In 2019, Jose enrolled at McGill University - Desautels Faculty of Management and completed the McGill X-1 S19 program. Jose focused on Business Administration, Management, and Operations during this period.

Between 2017 and 2018, Jose studied at McGill University and obtained a Master of Architecture (MArch) degree.

In 2014, Jose participated in an exchange program in Design at both the Rhode Island School of Design and Universidad de Palermo.

From 2012 to 2017, Jose attended Pontificia Universidad Javeriana and earned a Bachelor of Architecture (BArch) degree.

These are the only education experiences available and no further assumptions can be made.